The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files
NBER Working Paper No. 18552
---- Acknowledgements -----
This research was supported by the American Enterprise Institute, Novartis, and Pfizer. The sponsors placed no restrictions or limitations on data, methods, or conclusions, and had no right of review or control over the outcome of the research. The views expressed herein are those of the author and do not necessarily reflect the views of the National Bureau of Economic Research.